26 results on '"Chandra, Praveen"'
Search Results
2. Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication
3. Bempedoic Acid for Management of Dyslipidemia from an Indian Perspective: An Expert Consensus Report
4. Sirolimus-Coated Balloon With a Microsphere-Based Technology for the Treatment of De Novo or Restenotic Coronary Lesions
5. Current Lessons and Perspectives from the 2022 Virtual International Heart Failure Summit for Angiotensin Receptor-Neprilysin Inhibition (ARNI) as Revolutionary Drug Among Guideline-Based Treatments in Heart Failure with Reduced Ejection Fraction (HFrEF)
6. Sirolimus-Eluting Balloon With a Micro-Reservoir-Based Technology for the Treatment of De Novo Coronary Lesions – Subgroup Analysis of a Prospective, Multi-Center, Pivotal Single-Arm Trial
7. CRT-100.98 Sirolimus-Eluting Balloon With a Micro-Reservoir-Based Technology for the Treatment of De Novo Coronary Lesions – Subgroup Analysis of a Prospective, Multi-Center, Pivotal Single-Arm Trial
8. 30-Day and 1-Year Outcomes With HYDRA Self-Expanding Transcatheter Aortic Valve
9. First report of percutanious axillary IABP for heart failure from india
10. TCT-64 Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial
11. First ever transmitral valve in valve replacement in India
12. Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India
13. TCTAP A-058 Favorable Outcomes for Systemic Pharmacokinetic Study of Sirolimus-eluting Bioresorbable Vascular Scaffold System in Treating De Novo Native Coronary Artery Lesion: A Sub Study of MeRes-1 Trial
14. TCTAP A-003 First-in-human Evaluation of a Novel Poly-L-lactide Based Sirolimus-eluting Bioresorbable Vascular Scaffold for the Treatment of De Novo Native Coronary Artery Lesions: MeRes-1 Trial
15. CRT-700.01 Favourable Outcomes for Systemic Pharmacokinetic Study of Sirolimus-Eluting BioResorbable Vascular Scaffold System in Treating de novo Native Coronary Artery Lesion: A Sub Study of MeRes-1 Trial
16. Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial)
17. Current practices of Asia-Pacific cardiologists in the utilization of bioresorbable scaffolds
18. Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial
19. A prospective, multi-centric, observational registry to evaluate performance of Excel™ DES in ‘Real World, All Comers’ patient population
20. A prospective, multicenter, post marketing surveillance study to evaluate the safety and effectiveness of the Superia-Sirolimus Eluting Coronary Stent System (SSECSS) implanted during routine clinical practice in India
21. WITHDRAWN: A two year analysis of Diabetic subset ‘e-BioMatrix’ prospective, multicentric, all comers registry in India
22. The Paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: An angiographic follow up study
23. One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: The e-BioMatrix multicenter post marketing surveillance registry in India
24. A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients
25. A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: Rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial
26. Systemic exposure of everolimus after stent implantation: A pharmacokinetic study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.